BRIEF-Scancell updates on clinical trial
LONDON Jan 29 (Reuters) - Scancell Holdings PLC : * update on patient recruitment in clinical trial * treats final patient in the second part of its Phase 1/2 clinical trial of SCIB1,its DNA ImmunoBody vaccine being developed for the treatment of melanoma.
- Air strike kills 15 civilians in Yemen by mistake: officials
- North Korea executes leader's powerful uncle in rare public purge |
- Twitter backtracks on block feature after users revolt
- Insight: In Yemen, al Qaeda gains sympathy amid U.S. drone strikes
- Iran angry over U.S. sanctions, nuclear talks interrupted